Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cognitive Dysfunction × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 135 Breast Neoplasms 31 Prostatic Neoplasms 29 Insulin Resistance 27 Obesity 18 Pancreatic Neoplasms 13 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 11 Infertility 11 Colorectal Neoplasms 11 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Melanoma 7 Hyperandrogenism 7 Glioblastoma 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Rectal Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Urinary Bladder Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Recurrence 3

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Walking 3 Memantine 3 Tablets 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lime 1 enzalutamide 1 blueberry extract 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 Waiting Lists 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Transcranial Magnetic Stimulation 1 Time 1 Therapeutics 1 Tai Ji 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡